2019
DOI: 10.1016/j.pupt.2019.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Limitations of the results from randomized clinical trials involving intravenous and nebulised magnesium sulphate in adults with severe acute asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…Magnesium sulfate (MgSO 4 ) is reported to have a powerful relaxation of airway smooth muscle, so it is often proposed to treat asthma ( Javor and Grle, 2019 ). Liu et al found that the incidence of FIC declined from 50.0% to 20.0% and 5.4% after the usage of 30 and 50 mg⋅kg −1 of MgSO 4 , respectively.…”
Section: Prevention and Treatment Of Fentanyl-induced Coughmentioning
confidence: 99%
“…Magnesium sulfate (MgSO 4 ) is reported to have a powerful relaxation of airway smooth muscle, so it is often proposed to treat asthma ( Javor and Grle, 2019 ). Liu et al found that the incidence of FIC declined from 50.0% to 20.0% and 5.4% after the usage of 30 and 50 mg⋅kg −1 of MgSO 4 , respectively.…”
Section: Prevention and Treatment Of Fentanyl-induced Coughmentioning
confidence: 99%
“…3 Therefore, the role of magnesium sulphate in obtunding fentanyl-induced cough was investigated in clinical trials based on its properties as a calcium antagonist and smooth muscle relaxant. 12,13 In this study, the incidence of fentanyl-induced cough in the control group was 11.4%, where the dose of fentanyl was 2 μg/kg delivered over 3 seconds. The incidence of fentanyl-induced cough differs according to the patient's age group, fentanyl dosage, and the speed of fentanyl administration.…”
Section: Discussionmentioning
confidence: 67%
“…The hospital medicines policy design is a complex process, and requires an understanding of evidence-based medicine (EBM) and its translation into value-based medicine (VBM). The clinical pharmacist fulfilled these requirements by its competencies, [10][11][12][13][14][15][16][17][18] and was included in the DTC as an active member and redesigned the public procurement for medicines. The clinical pharmacist's approach in hospital medicines policy included encouraging rational, generic, therapeutically equivalent and biosimilar medicines prescribing, in line with regulations from the authorities, EBM and VBM data.…”
Section: Methodsmentioning
confidence: 99%